image credit: Freepik

Now is the time for pharma to help solve bias in clinical trials

September 7, 2022


The industry’s application of mRNA techniques during the pandemic led to the fastest vaccine development in history. The processes used are now seeing huge infrastructure commitments, in order to cement their place in the development of future products and trials.

But our drug development processes are not perfect. Pharma can always move faster, whilst prioritising patient health. And, at the heart of this, pharma cannot escape from the reality that the industry is operating with deep historical biases in collecting health data – from ethnic, to socio-economic, to gender biases. This issue – which contributes to the avoidable difference in health equity between different population groups – is one of the biggest facing the pharma industry today.

Read More on Pharmaphorum